Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers

Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung Cancers

The anticancer activities of Withaferin-A (Wi-A) and Withanone (Wi-N) from Ashwagandha and Caffeic Acid Phenethyl Ester (CAPE) from honeybee propolis have been well documented. Here, we examined the binding potential of these natural compounds to inhibit the constitutive phosphorylation of epidermal...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Vidhi Malik, Vipul Kumar, Sunil C. Kaul, Renu Wadhwa, Durai Sundar
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: MDPI AG 2021-01-01
Sarja:Biomolecules
Aiheet:
EGFR
exon 20 insertion mutations
Withaferin A
Withanone
Caffeic Acid Phenethyl Ester
ATP competitive inhibitors
Linkit:https://www.mdpi.com/2218-273X/11/2/160

Samankaltaisia teoksia

Samankaltaisia teoksia